307 related articles for article (PubMed ID: 8734736)
1. Radiotherapy for stage T3b transitional cell carcinoma of the bladder.
Pollack A; Zagars GZ
Semin Urol Oncol; 1996 May; 14(2):86-95. PubMed ID: 8734736
[TBL] [Abstract][Full Text] [Related]
2. Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone.
Cole CJ; Pollack A; Zagars GK; Dinney CP; Swanson DA; von Eschenbach AC
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):331-40. PubMed ID: 7751174
[TBL] [Abstract][Full Text] [Related]
3. Abnormal bcl-2 and pRb expression are independent correlates of radiation response in muscle-invasive bladder cancer.
Pollack A; Wu CS; Czerniak B; Zagars GK; Benedict WF; McDonnell TJ
Clin Cancer Res; 1997 Oct; 3(10):1823-9. PubMed ID: 9815569
[TBL] [Abstract][Full Text] [Related]
4. [Infiltrating transitional carcinoma of the bladder (I). Comparison of 2 groups treated with preoperative radiotherapy (long-term protocol and short-term protocol) + radical cystectomy versus radical cystectomy only. Analysis of local recurrence and metastasis].
Escudero Barrilero A; Allona A; Berenguer A; Burgos J; Castañeda A; Negrin A; Tellez M
Actas Urol Esp; 1991; 15(2):124-38. PubMed ID: 1807106
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer.
Chung PW; Bristow RG; Milosevic MF; Yi QL; Jewett MA; Warde PR; Catton CN; McLean M; Moore M; Tannock IF; Gospodarowicz MK
Urol Oncol; 2007; 25(4):303-9. PubMed ID: 17628296
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
[TBL] [Abstract][Full Text] [Related]
7. Radical cystectomy for stage T3b bladder cancer.
Hall CM; Dinney CP
Semin Urol Oncol; 1996 May; 14(2):73-80. PubMed ID: 8734734
[TBL] [Abstract][Full Text] [Related]
8. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of 34 cases of infiltrating carcinoma of the bladder treated exclusively with partial cystectomy (part 1)].
Escudero Barrilero A; Fernández Fernández E; Jiménez Cidre M; Maganto Pavón E; Mayayo Dehesa T; Rodríguez Rodríguez R; Galvis San Juan F; Burgos Revilla FJ
Arch Esp Urol; 1996 May; 49(4):349-64. PubMed ID: 8754191
[TBL] [Abstract][Full Text] [Related]
10. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
Kassouf W; Swanson D; Kamat AM; Leibovici D; Siefker-Radtke A; Munsell MF; Grossman HB; Dinney CP
J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803
[TBL] [Abstract][Full Text] [Related]
11. The relationship of local control to distant metastasis in muscle invasive bladder cancer.
Pollack A; Zagars GK; Cole CJ; Dinney CP; Swanson DA; Grossman HB
J Urol; 1995 Dec; 154(6):2059-63; discussion 2063-4. PubMed ID: 7500458
[TBL] [Abstract][Full Text] [Related]
12. p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.
Garcia del Muro X; Condom E; Vigués F; Castellsagué X; Figueras A; Muñoz J; Solá J; Soler T; Capellà G; Germà JR
Cancer; 2004 May; 100(9):1859-67. PubMed ID: 15112266
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
14. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
15. [Results of long-term treatment of inoperable cancer of the bladder with cisplatin and concurrent irradiation: prognostic factors of local control and survival].
Chauvet B; Félix-Faure C; Davin JL; Choquenet C; Alfonsi M; Reboul F
Cancer Radiother; 1998 Apr; 2 Suppl 1():85s-91s. PubMed ID: 9749086
[TBL] [Abstract][Full Text] [Related]
16. Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy.
Chauvet B; Brewer Y; Félix-Faure C; Davin JL; Choquenet C; Reboul F
J Urol; 1996 Oct; 156(4):1258-62. PubMed ID: 8808849
[TBL] [Abstract][Full Text] [Related]
17. Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma.
Granfors T; Tomic R; Ljungberg B
Scand J Urol Nephrol; 2009; 43(4):293-9. PubMed ID: 19363744
[TBL] [Abstract][Full Text] [Related]
18. [Radiotherapy in the interdisciplinary approach to the treatment of bladder carcinoma].
Dunst J
Strahlenther Onkol; 1991 Oct; 167(10):563-80. PubMed ID: 1948642
[TBL] [Abstract][Full Text] [Related]
19. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer.
Shariat SF; Tokunaga H; Zhou J; Kim J; Ayala GE; Benedict WF; Lerner SP
J Clin Oncol; 2004 Mar; 22(6):1014-24. PubMed ID: 14981102
[TBL] [Abstract][Full Text] [Related]
20. Bladder preservation and continent urinary diversion in T3b transitional cell carcinoma of the bladder.
Cespedes RD; McGuire EJ; Donat SM; Babaian RJ
Semin Urol Oncol; 1996 May; 14(2):103-11. PubMed ID: 8734738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
